Filter Results :

Your search for Biotech and Diagnostics returned 12 reports

Sort by


Stable Isotope Labeled Compounds Market by Type (C13, D, 018, N15 label), Application (Research, Clinical Diagnostics, Industrial), End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Hospital) - Global Forecast to 2022

26 Jul 2017  |  Published by:  MarketsandMarkets
The stable isotope-labeled compounds market is projected to grow at a CAGR of 2.94%.The global stable isotope-labeled compounds market is estimated to grow at a CAGR of 2.94% from 2017 to 2022, to reach USD 294.2 million by 2022. Increase in research activities in the pharmaceutical and biotechnolog...

$ 5,650.00
$ 4,237.50
( Save 25% )

Read More

Global Option and Evaluation Partnership Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2016

01 May 2017  |  Published by:  CurrentPartnering
The Global Option and Evaluation Deals in Pharma, Biotech and Diagnostics 2010-2016 report provides comprehensive understanding and unprecedented access to the option and evaluation partnering agreements entered into by the worlds leading biopharma companies The Global Option and Evalu...

$ 2,995.00

Read More

Global Asset Purchase Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010 to 2016

01 May 2017  |  Published by:  CurrentPartnering
The Global Asset Purchase Deals in Pharma, Biotech and Diagnostics 2010-2016 report provides a detailed understanding and analysis of how and why companies enter business, product, technology and royalty asset purchase deals "The Global Asset Purchase Deals in Pharma, Biotech and Diagnostic...

$ 2,995.00

Read More

Global Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2016

01 May 2017  |  Published by:  CurrentPartnering
The Global Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2016 report provides comprehensive understanding and unprecedented access to the manufacturing and supply agreements entered into by the world’s biopharma companies "The Global Manufa...

$ 2,995.00

Read More

Global Distribution Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010 to 2016

01 May 2017  |  Published by:  CurrentPartnering
The Global Distribution Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2016 report provides comprehensive understanding and unprecedented access to the distribution partnering agreements entered into by the worlds leading biopharma companies The Global Distribution ...

$ 2,995.00

Read More

Global Merger and Acquisition Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2017

01 Apr 2017  |  Published by:  CurrentPartnering
The Global Merger and Acquisition Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2017 report provides details of the latest merger and acquisition (M&A) agreements announced in the pharmaceutical, biotechnology, diagnostic and other lifescience sectors. Fully revised and updated, t...

$ 2,995.00

Read More

Global Collaborative R&D Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2012-2017

02 Feb 2017  |  Published by:  CurrentPartnering
The Global Collaborative R&D Partnering Terms & Agreements in Pharma, Biotech & Diagnostics 2010-2017 report provides comprehensive understanding and unprecedented access to the collaborative R&D partnering deals and agreements entered into by the worlds leading healthcare companies ...

$ 2,995.00

Read More

Global Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2010-2017

01 Feb 2017  |  Published by:  CurrentPartnering
The Global Co-promotion and Co-marketing Partnering Terms & Agreements in Pharma, Biotech & Diagnostics 2010-2017 report provides comprehensive understanding and unprecedented access to the co-promotion and co-marketing partnering agreements entered into by the worlds leading healthcare comp...

$ 2,995.00

Read More

Global Royalty Financing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2017

01 Feb 2017  |  Published by:  CurrentPartnering
The Global Royalty Financing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2017 report provides comprehensive understanding and unprecedented access to the royalty financing partnering agreements entered into by the worlds leading healthcare companies "The Global Royalty Fi...

$ 1,995.00

Read More

Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010 to 2017

01 Feb 2017  |  Published by:  CurrentPartnering
The Global Co-development Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2010-2017 report provides comprehensive understanding and unprecedented access to the co-development deals and agreements entered into by the worlds leading healthcare companies "The Global Co-development ...

$ 2,995.00

Read More

Global Joint Venture Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2017

01 Feb 2017  |  Published by:  CurrentPartnering
The Global Joint Venture Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2017 report provides comprehensive understanding and unprecedented access to the joint venture partnering agreements entered into by the worlds leading healthcare companies "The Global Joint Venture Part...

$ 1,995.00

Read More

Global Royalty Financing Deals in Pharma, Biotech and Diagnostics 2010-2015

01 Jun 2015  |  Published by:  CurrentPartnering
The Global Royalty Rate Trends in Pharma and Biotech Dealmaking 2005-2015 report is your one-stop source for providing real-deal information on hundreds of transactions, including the technology licensed, royalty rates, license fees, upfront and milestone payments. This report provides deta...

$ 2,995.00

Read More
Total 12 records.